Supply of GemCell Human Serum for UCalgary CAR T Cell Manufacturing
Awarded 26 Feb 2025
About
The University of Calgary awarded a contract to VWR International Co.
for the supply of GemCell™ Plus Xeno-free Human Serum (AB Serotype) and GemCell™ U.S.
Origin Human Serum (AB Serotype).
This serum is a critical component in the validated processes supporting the Riddell Centre for Cancer Immunotherapy's CAR T cell manufacturing program and Clinical Trial Application (CTA) to Health Canada.
The specific serum lot has been used extensively in validation work and meets stringent requirements for clinical-grade applications.
Regulatory guidelines mandate continued use of the same lot during the clinical trial to maintain consistency with data submitted in the CTA; any deviation would require revalidation, causing delays and additional costs.
The contract value was CAD 1.
Similar open tenders12
GovMarket
We do the hard work.
You win the work.
We find the tenders, read the documents and track who wins, so your time goes on bids you can win.





